1. Home
  2. STRO vs NAUT Comparison

STRO vs NAUT Comparison

Compare STRO & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • NAUT
  • Stock Information
  • Founded
  • STRO 2003
  • NAUT 2016
  • Country
  • STRO United States
  • NAUT United States
  • Employees
  • STRO N/A
  • NAUT N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • NAUT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • STRO Health Care
  • NAUT Industrials
  • Exchange
  • STRO Nasdaq
  • NAUT Nasdaq
  • Market Cap
  • STRO 292.6M
  • NAUT 284.7M
  • IPO Year
  • STRO 2018
  • NAUT N/A
  • Fundamental
  • Price
  • STRO $4.38
  • NAUT $2.49
  • Analyst Decision
  • STRO Strong Buy
  • NAUT Buy
  • Analyst Count
  • STRO 8
  • NAUT 2
  • Target Price
  • STRO $12.13
  • NAUT $4.50
  • AVG Volume (30 Days)
  • STRO 482.6K
  • NAUT 79.8K
  • Earning Date
  • STRO 11-19-2024
  • NAUT 10-29-2024
  • Dividend Yield
  • STRO N/A
  • NAUT N/A
  • EPS Growth
  • STRO N/A
  • NAUT N/A
  • EPS
  • STRO N/A
  • NAUT N/A
  • Revenue
  • STRO $169,359,000.00
  • NAUT N/A
  • Revenue This Year
  • STRO N/A
  • NAUT N/A
  • Revenue Next Year
  • STRO N/A
  • NAUT N/A
  • P/E Ratio
  • STRO N/A
  • NAUT N/A
  • Revenue Growth
  • STRO 197.83
  • NAUT N/A
  • 52 Week Low
  • STRO $2.01
  • NAUT $2.19
  • 52 Week High
  • STRO $6.13
  • NAUT $3.46
  • Technical
  • Relative Strength Index (RSI)
  • STRO 68.55
  • NAUT 41.21
  • Support Level
  • STRO $3.22
  • NAUT $2.46
  • Resistance Level
  • STRO $3.74
  • NAUT $2.92
  • Average True Range (ATR)
  • STRO 0.26
  • NAUT 0.15
  • MACD
  • STRO 0.10
  • NAUT -0.02
  • Stochastic Oscillator
  • STRO 93.55
  • NAUT 10.46

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

About NAUT Nautilus Biotechnolgy Inc.

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.

Share on Social Networks: